What is the current valuation of the regenerative medicine market in France?

The market valuation was $1053.25 Million in 2024. Read More

What is the projected market size for regenerative medicine in France by 2035?

The projected valuation for 2035 is $2411.0 Million. Read More

What is the expected CAGR for the France regenerative medicine market from 2025 to 2035?

The expected CAGR during this period is 7.82%. Read More

Which therapeutic area is expected to have the highest market valuation in France?

Cardiovascular diseases are projected to reach $300.0 - $700.0 Million. Read More

What are the key product types in the France regenerative medicine market?

Key product types include Cell Therapy, Gene Therapy, Tissue Engineering, and Stem Cell Therapy. Read More

Which end user segment is anticipated to dominate the regenerative medicine market in France?

Hospitals are expected to lead with a valuation of $421.3 - $1000.0 Million. Read More

Who are the major players in the France regenerative medicine market?

Key players include Acelity, Organogenesis, Mesoblast, and Vericel. Read More

What is the market valuation for oncology applications in France?

The oncology segment is valued between $303.25 Million and $711.0 Million. Read More

How does the market for chronic wounds compare to other therapeutic areas?

The chronic wounds segment is projected to range from $403.25 Million to $911.0 Million. Read More

What is the market size for tissue engineering in France?

The tissue engineering segment is expected to reach $300.0 - $700.0 Million. Read More

France Regenerative Medicine Market

ID: MRFR/MED/50809-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

France Regenerative Medicine Market Research Report: Size, Share, Trend Analysis By Applications (Orthopedics, Neurology, Cardiology, Dermatology, Oncology), By Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, Stem Cell Therapy), By End Users (Hospitals, Research Laboratories, Pharmaceutical Companies, Academic Institutions) and By Therapeutic Area (Musculoskeletal Disorders, Cognitive Disorders, Cardiovascular Diseases, Chronic Wounds) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Orthopedics
  2. 4.1.2 Neurology
  3. 4.1.3 Cardiology
  4. 4.1.4 Dermatology
  5. 4.1.5 Oncology
2. 4.2 Medical Device, BY Product Type (USD Million)
  1. 4.2.1 Cell Therapy
  2. 4.2.2 Gene Therapy
  3. 4.2.3 Tissue Engineering
  4. 4.2.4 Stem Cell Therapy
3. 4.3 Medical Device, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Research Laboratories
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Academic Institutions
4. 4.4 Medical Device, BY Therapeutic Area (USD Million)
  1. 4.4.1 Musculoskeletal Disorders
  2. 4.4.2 Cognitive Disorders
  3. 4.4.3 Cardiovascular Diseases
  4. 4.4.4 Chronic Wounds
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Acelity (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Organogenesis (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mesoblast (AU)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Vericel (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Tigenix (BE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sangamo Therapeutics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Regenative Labs (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Cytori Therapeutics (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Kite Pharma (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION
3. 6.3 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 FRANCE MARKET ANALYSIS BY END USER
5. 6.5 FRANCE MARKET ANALYSIS BY THERAPEUTIC AREA
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France France Regenerative Medicine Market Segmentation

France Regenerative Medicine Market By Application (USD Million, 2025-2035)

Orthopedics
Neurology
Cardiology
Dermatology
Oncology

France Regenerative Medicine Market By Product Type (USD Million, 2025-2035)

Cell Therapy
Gene Therapy
Tissue Engineering
Stem Cell Therapy

France Regenerative Medicine Market By End User (USD Million, 2025-2035)

Hospitals
Research Laboratories
Pharmaceutical Companies
Academic Institutions

France Regenerative Medicine Market By Therapeutic Area (USD Million, 2025-2035)

Musculoskeletal Disorders
Cognitive Disorders
Cardiovascular Diseases
Chronic Wounds

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”